NCT05898165Active, not recruiting
Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): Pilot Study
Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): Pilot Study of a Risk Score for Early Detection of Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 2 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to trial a new intervention - risk-guided AF screening using an EHR-based risk score and remote ECG monitoring process - and to characterise individuals at elevated predicted AF risk.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1955 (estimated)
- First submitted
- 18 May 2023
- Start date
- 1 Oct 2023
- Primary completion date
- 16 Jun 2025
- Lead sponsor
- University of Leeds
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT05898165
What you commit to
- Study type: Observational
- Planned participants: 1955
- From 1 Oct 2023 to the primary completion date, 16 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- On anticoagulation therapy
Other
- Known diagnosis of AF
- On the palliative care register
- Unable to give written informed consent for participation in the study
- Unable to adhere to the study requirements
Who the study is looking for
- Age at enrolment ≥30 years
- Men with CHA2DS2VASC ≥ 2 and women with a CHA2DS2VASC ≥ 3
Age in the registry: 30 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Leeds Coordinator of this site? Confirm its status | Leeds | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.